Navigation Links
Intense Cessation Treatment Proves Successful in High-Risk Smokers

Hospitalized patients who undergo structured treatment to quit smoking are significantly more likely to remain// smoke-free, says a new study. A new research suggests that high-risk smokers with acute cardiovascular disease are more likely to quit smoking when treated with an intensive smoking cessation program.

“Smoking is the greatest risk factor for patients with heart disease,” said author Syed M. Mohiuddin, MD, FCCP, Creighton University Cardiac Center, Omaha, NE, “and our study showed that intense treatment intervention not only succeeded in getting patients to quit smoking, but it reduced hospitalizations and mortality, as well.”

From January 2001 to December 2002, Dr. Mohiuddin and colleagues gathered 209 patients who were admitted to the coronary care unit at the Creighton University Cardiac Center, suffering from unstable angina, heart attack, or severe coronary heart disease. All of the patients were self-identified smokers and agreed to undergo smoking cessation intervention. Patients were then randomized into two groups: the intensive intervention group (109) and the usual care group (100).

Prior to hospital discharge, all patients received approximately 30 minutes of counseling and were given self-help materials. Treatment in the intervention group also included a minimum 12 weeks of behavior modification counseling, coupled with individualized pharmacotherapy. This included nicotine replacement therapy and/or bupropion at no cost to the patient. However, patients in the usual care group did not receive anything beyond the initial inpatient counseling session.

“The intensive component of tobacco cessation therapy was started while patients were hospitalized but continued after release,” said Dr. Mohiuddin, “making the outpatient portion of this program the most significant element.”

All participants returned at 3, 6, 12, and 24 months, during which follow-up medical histories and expired c arbon monoxide levels were obtained. Patients who reported having not smoked during the previous evaluation period and who were confirmed by a negative expired carbon monoxide were classified as “abstinent.” Those patients who were confirmed as not smoking by their expired carbon monoxide at every visit were classified as “continuously abstinent.”

Compared with the usual care group, patients in the intensive treatment group had significantly higher quit rates at all follow-up time intervals. At the two-year follow-up, 39 percent of the intensive treatment group was continuously abstinent, compared with only 9 percent of the usual care group. Additionally, treatment was shown to reduce the risk of hospitalization by nearly half. Researchers also found that those in the control group were four times as likely to die than were patients in the intervention group.

“Cessation of smoking results in an almost immediate improvement in the risk of heart attack,” said Dr. Mohiuddin, “and our study proves that intense smoking cessation treatment in high-risk patients is successful and that it saves lives.”

“Smoking clearly links patients with cardiovascular disease to adverse outcomes,” said Mark J. Rosen, MD, FCCP, President of the American College of Chest Physicians. “It's never too late to quit smoking and all patients who smoke should work with their doctors to find the quit method that works best for them.”

Souce-Newswise
SRM
'"/>




Related medicine news :

1. Intense Fight Against Polio In India Gets Results
2. Drinkers Intensed to get Drunk
3. Anticipation Could Have An Intense Effect On Memory
4. Yearning -the Most Intense Emotion in Bereavement
5. Direct To Home: Television Provides Powerful Fillip to Smoking Cessation Campaigns.
6. Smoking Cessation Would Be Beneficial For the Recovery of Alcoholics
7. Smoking Ban Lights Up Smoking-Cessation Initiatives
8. Cessation of blood supply to cancer cells may curtail spread, novel research
9. Is Nicotine Lozenge A Safe Smoking Cessation Product?
10. Teen Smoking Cessation Programs Improve Quit Rates
11. Smoking Cessation Therapy May be Harmful for ICU Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... ... September 19, 2017 , ... Spain’s popular line ... Laboratories, is coming soon to RonnieColemanNutrition.com. , ACPG Laboratories has been in ... trusted, well-respected brand reliant on the healing properties of plants, a proven science ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... to serve as strategic adviser to the animal healthcare division of Sonoma ... Bridge Animal Referral Center (BARC) in Edmonds, Washington, which specializes in compassionate ...
(Date:9/19/2017)... ... , ... Premiere Long Island dental office Gold Coast Smiles is pleased to ... dentists in America under age 40 by Incisal Edge magazine. , Incisal Edge ... the best 40 dentists under the age of 40 renowned for medical innovations and ...
(Date:9/19/2017)... ... September 19, 2017 , ... When it comes to household ... deserve clear instructions on how to keep babies and toddlers safe, and there's no ... Safety Month. , Great Time to Check Labels, Brands that sell all kinds of ...
(Date:9/19/2017)... ... September 19, 2017 , ... Emergency ... the Certified Emergency Nurse (CEN®) certification according to a large-scale study ... of certification study, conducted by the Human Resources Research Organization (HumRRO) in late ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... TORONTO , Sept. 6, 2017 /PRNewswire/ ... new knowledge and skills while treating their ... for hands-on experience without involving patients. Simulation ... skills. Clinicians can carry out procedures, refine ... at risk. Integration of new technology, such ...
(Date:9/5/2017)... KEYSTONE, Colo. , Sept. 5, 2017 ... their XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party ... update existing CT scanners and allows compliance with current ... The Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically ... notifications and alerts of potential radiation doses over a ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... company focused on the development of oral drug delivery ... meeting with the U.S. Food and Drug Administration (FDA) ... At the meeting, the ... submission of ORMD-0801, would be a Biologics License Application ...
Breaking Medicine Technology: